Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
4
67%
Ph phase_2
2
33%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
2(33.3%)
N/ANon-phased studies
4(66.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

6

all time

Status Distribution
Active(2)
Completed(1)
Terminated(1)
Other(2)

Detailed Status

Recruiting2
unknown2
Completed1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
2
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 22 (33.3%)
N/A4 (66.7%)

Trials by Status

completed117%
recruiting233%
unknown233%
withdrawn117%

Recent Activity

Clinical Trials (6)

Drug Details

Intervention Type
DEVICE
Total Trials
6